24 January 2024
Oxford PharmaGenesis has contributed to the development of the new ACCORD reporting guideline to help the medical and scientific communities to improve the reporting of research involving consensus methodologies. The guideline was published in the non-profit open access journal PLOS Medicine.
Oxford PharmaGenesis was delighted to attend the West Meeting of the International Society for Medical Publication Professionals (ISMPP), which took place on 14 and 15 November 2019 in San Diego, CA, USA.
Maureen Lloyd,1 Cynthia K Barbitsch,2 Mary Voehl Hirsch,3 Antonia Panayi,4 Eric Southam5
Continued growth has led Oxford PharmaGenesis, the leading HealthScience communications consultancy, to create a new UK office in Cambridge.
In mid-November Barcelona played host to the World Orphan Drug Congress 2019, Europe’s largest commercially focused conference for the rare disease community. Representatives from Oxford PharmaGenesis were in attendance over the 3-day meeting. The conference was broad-ranging in terms of sessions and speakers; however, there were some sessions of particular note.
Empowerment, not tokenism. Earlier this month, members of the Oxford PharmaGenesis Patient Engagement Team attended the annual educational event hosted by the Project Management Society in London. The event was held at the British Academy on the Mall, and featured several speakers and an expert panel selected to explore what it means to co-create with…
Oxford PharmaGenesis Inc. has been named as a Great Place to Work® for the third consecutive year!
